Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...
We believe this recognition from the IDC MarketScape validates our approach to solving one of healthcare's most ...
New data science-driven alert framework expected to reduce clinician burden by 45% while preserving industry-leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback